Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 675 M755 M829 M940 M794 M 3.32 B Research & development ————— — Operating income 107 M-603 M-116 M-200 M602 M -317 M Non-Operating Income, Total -352 M-546 M-697 M-309 M-425 M -1.98 B Interest expense, net of interest capitalized 347 M338 M319 M280 M225 M 1.16 B Non-Operating Income, excl. Interest Expenses -382 M-574 M-714 M-354 M-451 M -2.09 B Unusual income/expense 30 M28 M17 M45 M26 M 116 M Pretax income -245 M-1.15 B-813 M-509 M177 M -2.29 B Equity in earnings ————— — Taxes -44 M-234 M-192 M-507 M377 M -556 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -201 M-915 M-621 M-2 M-200 M -1.74 B Discontinued operations ————— — Net income -201 M-915 M-621 M-2 M-200 M -1.74 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -201 M-915 M-621 M-2 M-200 M -1.74 B Basic earnings per share (Basic EPS) -0.2-0.92-0.62-0.01-0.2 -1.75 Diluted earnings per share (Diluted EPS) -0.2-0.92-0.62-0.01-0.2 -1.75 Average basic shares outstanding 991.27 M994.54 M996 M994.55 M998.89 M — Diluted shares outstanding 991.27 M994.54 M996 M994.55 M998.89 M — EBITDA 820 M85 M558 M474 M1.27 B 2.38 B EBIT 107 M-603 M-116 M-200 M602 M -317 M Cost of revenue 1.69 B1.62 B1.7 B1.63 B1.44 B 6.39 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 713 M688 M674 M674 M664 M 2.7 B